comparemela.com
Home
Live Updates
Sapience Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ST101 : comparemela.com
Sapience Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ST101
/PRNewswire/ -- Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address...
Related Keywords
,
Barry Kappel
,
Amy Conrad
,
Alice Bexon
,
Columbia University Irving Medical Center
,
Columba University
,
Linkedin
,
European Commission
,
Drug Administration
,
Sapience Therapeutics Inc
,
Sapience Therapeutics
,
Chief Medical
,
Fast Track
,
Chief Executive
,
Investor Contact
,
Nc
,
comparemela.com © 2020. All Rights Reserved.